human norovirus honor signifies caps act gastroenter develop world yet understand molecular pathway involve noroviru replica pathogenesis limit final office culture virus laboratory use marin mn model recent identify network host factor interact extreme rna genome admit number wellknown cellular bind protein chaperone sp common ribonucleoprotein complex show inhibit active neg impact cell smallmoleculemedi mag dimethylaminoethylaminodemethoxygeldanamycin reveal play pleiotrop role life cycle static viral caps protein inter link furthermore demons require target vivo significantly reduce virus summary proteostasi inhibit identify potent novel therapeutic target treatment infect import major around include reli heavily aspect identify one import factor require small molecule inhibitor also reduce infect product given consider interest develop use cancer therapeutic new could explore antivirus strategy control outbreak treat chronic infect immunosuppress patient 